LH Stock Overview
Operates as a laboratory services company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
Rewards
Trading at 59.4% below our estimate of its fair value
Earnings are forecast to grow 20.14% per year
Risk Analysis
Has a high level of debt
Large one-off items impacting financial results
Significant insider selling over the past 3 months
Profit margins (3.2%) are lower than last year (6.7%)
Labcorp Holdings Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$210.59 |
| 52 Week High | US$243.30 |
| 52 Week Low | US$195.01 |
| Beta | 1.01 |
| 1 Month Change | 4.52% |
| 3 Month Change | -2.36% |
| 1 Year Change | -3.67% |
| 3 Year Change | -22.37% |
| 5 Year Change | 26.25% |
| Change since IPO | 763.96% |
Recent News & Updates
Recent updates
Shareholder Returns
| LH | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0.1% | 1.5% | 1.8% |
| 1Y | -3.7% | 6.7% | 26.1% |
Return vs Industry: LH underperformed the US Healthcare industry which returned 6.7% over the past year.
Return vs Market: LH underperformed the US Market which returned 26.1% over the past year.
Price Volatility
| LH volatility | |
|---|---|
| LH Average Weekly Movement | 2.6% |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 16.1% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: LH has not had significant price volatility in the past 3 months.
Volatility Over Time: LH's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 61,975 | Adam Schechter | www.labcorp.com |
Labcorp Holdings Inc. operates as a laboratory services company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests.
Labcorp Holdings Inc. Fundamentals Summary
| LH fundamental statistics | |
|---|---|
| Market cap | US$17.75b |
| Earnings (TTM) | US$399.20m |
| Revenue (TTM) | US$12.30b |
44.5x
P/E Ratio
1.4x
P/S Ratio
Is LH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LH income statement (TTM) | |
|---|---|
| Revenue | US$12.30b |
| Cost of Revenue | US$8.89b |
| Gross Profit | US$3.41b |
| Other Expenses | US$3.01b |
| Earnings | US$399.20m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.74 |
| Gross Margin | 27.74% |
| Net Profit Margin | 3.25% |
| Debt/Equity Ratio | 64.8% |
How did LH perform over the long term?
See historical performance and comparisonDividends
1.4%
Current Dividend Yield
62%
Payout Ratio
Does LH pay a reliable dividends?
See LH dividend history and benchmarks| Labcorp Holdings dividend dates | |
|---|---|
| Ex Dividend Date | May 24 2024 |
| Dividend Pay Date | Jun 12 2024 |
| Days until Ex dividend | 3 days |
| Days until Dividend pay date | 22 days |
Does LH pay a reliable dividends?
See LH dividend history and benchmarks